With his scientific background and broad technology transfer experience, Mankit is actively involved in identifying and evaluating investment opportunities, and in supporting portfolio companies.
Prior to joining Pappas Capital in 2015, Mankit was an Associate in the Office of Technology Development at the University of North Carolina at Chapel Hill. During his tenure, he led the negotiation of contracts governing the development, allocation, and commercialization of existing and prospective intellectual property rights for a portfolio of life sciences technologies. He also served as an active member of the Association of University Technology Managers and the Licensing Executives Society. Before joining the Office of Technology Development, Mankit was the Innovation and Entrepreneurship Fellow of the UNC Eshelman School of Pharmacy, where he was an intellectual property scout and a technology transfer advisor for the School’s inventors and start-up ventures. Earlier in his career, Mankit was a postdoctoral fellow of the UNC Lineberger Comprehensive Cancer Center. With a decade of experience as a medical technologist and researcher, he has authored five peer-reviewed publications and was awarded the Ruth L. Kirschstein National Research Service Award from the National Cancer Institute.
Mankit currently serves as a board observer for Glycomine.
The Pennsylvania State University (BS in Biotechnology)
The Pennsylvania State University (PhD in Immunology and Infectious Diseases)
The University of North Carolina at Chapel Hill (MBA)
© 2019 Pappas Capital, LLC. ALL RIGHTS RESERVED.